HPV18 E6-i-galactosidase fusion protein was used as the immunogen for this HPV-16 E6 + HPV-18 E6 antibody cocktail.
Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.
Klonalität:
Monoclonal
Konzentration:
1 mg/ml in 1X PBS, BSA free, sodium azide free
Klon-Bezeichnung:
[HPV16/1295 + HPV18/1297]
Isotyp:
Mouse IgG1, kappa
Puffer:
1 mg/ml in 1X PBS, BSA free, sodium azide free
Reinheit:
Protein G affinity chromatography
Formulierung:
1 mg/ml in 1X PBS, BSA free, sodium azide free
Target-Kategorie:
HPV-16 E6 + HPV-18 E6
Antibody Type:
Primary Antibody
Application Verdünnung:
Immunohistochemistry (FFPE): 1-2ug/ml
Anwendungsbeschreibung:
Optimal dilution of the HPV-16 E6 + HPV-18 E6 antibody cocktail should be determined by the researcher.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
